Hyperbaric oxygen before chemotherapy for breast cancer
Part of Cancer, Skin clinical trials.
This study tests whether giving hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy can help shrink breast tumors more effectively. It is for women with triple-negative or HER2-positive breast cancer who are scheduled for neoadjuvant therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 to 60 years.
- You have been diagnosed with early-stage but locally advanced breast cancer (stage II or III) that is either triple-negative or HER2-positive.
- You have not had any prior cancer treatment for this breast cancer (neoadjuvant setting).
- You are in generally good health, able to perform daily activities, and your heart, liver, kidney, and blood counts are within acceptable limits.
- You have not had hyperbaric oxygen therapy before.
- You do not have distant metastases (cancer spread to other organs) or other active cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests adding hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard chemotherapy for breast cancer. The goal is to see if it helps shrink the tumor more effectively before surgery.
This trial tests whether giving hyperbaric oxygen (breathing pure oxygen in a pressurized chamber) before standard treatment can help shrink hormone receptor-positive breast cancer tumors. It aims to see if this added treatment is safe and effective.
This study tests if breathing pure oxygen in a special chamber can help reduce tingling, numbness, or pain in hands and feet caused by paclitaxel chemotherapy for breast cancer. It aims to see if this treatment can improve nerve function and quality of life.
This trial tests a combination of an oral chemotherapy pill (paclitaxel) with two targeted antibodies (pertuzumab and trastuzumab) given before surgery for HER2-positive breast cancer. The goal is to shrink the tumor and make surgery more effective.
This trial tests whether breathing pure oxygen in a pressurized chamber (hyperbaric oxygen) can prevent lung inflammation caused by breast cancer radiation. It may help reduce the risk of radiation pneumonitis in certain breast cancer survivors.
This trial tests a combination of targeted drugs and chemotherapy before surgery for HER2-positive breast cancer. It aims to see if this approach can shrink or eliminate the tumor, making surgery more effective.
Hear when a new Breast Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.